Sustainability | March 21, 2025
Lupin bags EcoVadis Silver Medal for sustainability excellence
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Amifampridine Tablets, 10 mg are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older.
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
the inspection conducted from January 27 to January 31, 2025
This rating reflects Lupin's leadership in environmental transparency and performance
Revenue up 11% to Rs 5,768 crore as compared to Rs 5,197 crore
Ipratropium Bromide Nasal Solution is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis
TFOS is indicated for the treatment of pulmonary arterial hypertension
The inspection was carried out from January 28 to February 1, 2025
Subscribe To Our Newsletter & Stay Updated
